在急性喘中心肺呼吸系统相互作用
Morgan Caplan1, Olfa Hamzaoui1,2
1Service de Médecine Intensive Réanimation, Hôpital Robert Debré, Université de Reims, Reims, France.
Frontiers in physiology
|October 2, 2023
概括
急性喘恶化通过复杂的心肺相互作用影响呼吸和心脏功能. 脉冲悖论可以帮助在床边评估喘严重程度和治疗反应.
科学领域:
- 肺部医学 肺部医学
- 心脏病学 心脏病学
- 关键护理医学 关键护理医学
背景情况:
- 喘包括间歇性呼吸道症状和可逆的空气流量限制.
- 由于对呼吸机机制的影响,急性喘恶化会带来危及生命的风险.
- 喘通过心肺相互作用显著影响心血管系统.
研究的目的:
- 探索急性喘恶化对心血管的影响.
- 阐明将喘恶化与心脏功能障碍联系在一起的机制.
- 评估Pulsus paradoxus在评估喘严重程度和治疗反应方面的有用性.
主要方法:
- 对喘中心肺相互作用背后的生理机制的审查.
- 分析动态高通胀和增加的呼吸工作如何影响心脏功能.
- 检查脉冲悖论作为胸内压力波动的指标.
主要成果:
- 动态高通胀和增加的呼吸工作改变心脏功能和输出.
- 机制包括增加静脉回流,增加右心室后负荷和心室相互依赖.
- 脉冲悖论量化了严重恶化期间夸张的心肺相互作用.
结论:
- 急性喘恶化会对心血管产生严重的后果.
- 了解心肺相互作用对于治疗严重喘至关重要.
- 脉冲悖论是一种有价值的,非侵入性的床边工具,用于评估急性喘的严重程度和治疗疗效.
相关概念视频
Acute Respiratory Failure-IV
172
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
172
Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Asthma-I: Introduction
2.7K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.7K
Antiasthma Drugs: β2-Adrenoceptor Agonists
290
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
290
Acute Respiratory Failure-V
155
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
155
Acute Respiratory Failure-II
263
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
263


